Trial Profile
Sevelamer Carbonate for Reducing Endotoxemia and Immune Activation: A Proof of Concept Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sevelamer (Primary)
- Indications Endotoxinaemia
- Focus Proof of concept; Therapeutic Use
- 15 Dec 2015 New trial record